Univariate and multivariate regression analysis to predict creatinine increase in 24–72 h compared with baseline
| Univariate analysis | Multivariate analysis | |||
| Standardised coefficient | p Value | Standardised coefficient | p Value | |
| Age | 0.02 | 0.76 | ||
| Sex | −0.06 | 0.31 | ||
| Onset-to-treatment time | 0.01 | 0.90 | ||
| National Institutes of Health Stroke Scale baseline | 0.00 | 0.98 | ||
| Performance of CT angiography | −0.04 | 0.52 | ||
| Blood pressure systolic at baseline | −0.03 | 0.60 | ||
| C reactive protein level at baseline | 0.25 | 0.0001 | −0.72 | 0.003 |
| Creatinine level at baseline | 0.24 | 0.0001 | −0.67 | 0.014 |
| Haemoglobin level at baseline | −0.07 | 0.28 | ||
| Platelets count at baseline | 0.16 | 0.009 | ||
| Activated partial thromboplastin time level at baseline | 0.05 | 0.45 | ||
| Fibrinogen level at baseline | 0.16 | 0.01 | ||
| Glucose level at baseline | 0.07 | 0.24 | ||
| Total contrast dose | −0.09 | 0.33 | ||
| History of hypertension | −0.08 | 0.18 | ||
| History of diabetes mellitus | 0.01 | 0.93 | ||
| History of coronary artery disease | 0.06 | 0.33 | ||
| History of congestive heart failure | 0.13 | 0.036 | ||
| History of nephropathy | 0.19 | 0.002 | ||
| History of cigarette smoking | −0.02 | 0.81 | ||
| Atrial fibrillation | 0.03 | 0.61 | ||
| Performance of additional intervention | 0.02 | 0.75 | ||